Received Feb 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
Hypertrophic cardiomyopathy; shortness of breath; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for covid-19 immunization. The following information was reported: HYPERTROPHIC CARDIOMYOPATHY (medically significant), outcome "unknown"; DYSPNOEA (non-serious), outcome "unknown", described as "shortness of breath". The patient underwent the following laboratory tests and procedures: Diagnostic procedure: (unspecified date) Unknown results; (Jul2023) confirmed shortness of breath; Electrocardiogram: (unspecified date) Unknown results; (unspecified date) Unknown results, notes: 2nd EC. Clinical course: During COVID-19, the patient had to get vaccinated because [City] required doses for almost everything. However, the patient did it because of work. The patient had to be vaccinated to attend the patient's players' hockey games. Following COVID-19, when the patient resumed training, the patient felt a slight difference in breathing, not alarming but the patient could see that there was a difference. It was getting worse and worse, but the patient did not pay much attention to it. In Aug2022 the patient left to register the patient's company. Having an apartment in [City], continuing to have a "pied-a-terre" in the city, and continuing training in the patient's daily life. In July2023, doin tests in the city so as not have any problems back since the patient cannot have an insurance policy for protection. At that time, they came back to the patient and confirmed shortness of breath, at the same time they asked the patient to check everything. The patient met a cardiologist and a family doctor in City luckily because they also found this shortness of breath intriguing. The patient had tests and an EC cardiogram, the cardiologist wanted to have the patient have an EC cardiogram every year. So it was at the patient's 2nd EC cardiogram that the patient was screened for this rare disease, Hypertrophic Cardiomyopathy. Breathing was increasingly difficult and above all, the obligation to no longer do high-intensity exercise. The patient stated that all this started from the results of the vaccine, before all that, the patient had no problems. The patient was taking the time to write before starting the procedures because the patient was officially 200% certain that this was caused by the 2 vaccines. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Test Name: Tests; Result Unstructured Data: Test Result:Unknown results; Test Date: 202307; Test Name: Tests; Result Unstructured Data: Test Result:confirmed shortness of breath; Test Name: EC Cardiogram; Result Unstructured Data: Test Result:Unknown results; Test Name: EC Cardiogram; Result Unstructured Data: Test Result:Unknown results; Comments: 2nd EC